Sibilot, D. L. M., Baranzelli, A., Leprieur, E. G., Amrane, K., Leleu, O., Zouak, A., Molinier, O., Treut, J. H. L., Souquet, P., Langlais, A., Morin, F., Cortot, A. B., Falchero, L. (2026). Paclitaxel, carboplatin, and durvalumab in extensive stage small-cell lung cancer (ES-SCLC; IFCT-2203 TAXIO phase II trial): Can we improve the chemotherapy (CT) immunotherapy combination in SCLC?. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8091